📰 Abt News
Page 184 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
April 5, 2023
Dupont Capital Management Corp trimmed its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 15.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,770 shares of the healthcare product maker’s stock after selling 6,770 shares […]
April 4, 2023
Daymark Wealth Partners LLC acquired a new position in Abbott Laboratories (NYSE:ABT – Get Rating) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 60,476 shares of the healthcare product maker’s stock, valued at approximately $6,640,000. Abbott Laboratories makes up […]
April 4, 2023
Private Wealth Partners LLC increased its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 30.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,071 shares of the healthcare product maker’s stock after acquiring an additional 5,608 shares during […]
April 4, 2023
First American Trust FSB boosted its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 1.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 73,680 shares of the healthcare product maker’s stock after acquiring an additional 802 shares during the […]
April 4, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) had its target price raised by SVB Leerink from $90.00 to $102.00 in a research report report published on Friday morning, Stock Target Advisor reports. SVB Leerink currently has a market perform rating on the healthcare product maker’s stock. ABT has been the topic of several other research reports. […]
April 4, 2023
ARS Investment Partners LLC reduced its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 31.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,450 shares of the healthcare product maker’s stock after selling 2,500 shares during the period. ARS […]
April 4, 2023
Sumitomo Mitsui DS Asset Management Company Ltd raised its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 6.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 139,073 shares of the healthcare product maker’s stock after purchasing an additional 7,880 shares during […]
April 4, 2023
S. R. Schill & Associates lifted its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 26.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,032 shares of the healthcare product maker’s stock after purchasing an additional […]
April 4, 2023
Unique Wealth LLC acquired a new stake in Abbott Laboratories (NYSE:ABT – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 2,170 shares of the healthcare product maker’s stock, valued at approximately $238,000. Other institutional investors have also recently bought and […]
April 4, 2023
Westhampton Capital LLC raised its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 10.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,300 shares of the healthcare product maker’s stock after acquiring an additional 700 shares during the quarter. Westhampton […]